Notably, serum adiponectin levels in the control group were comparable to those in patients with moderate disease (p = 0.128), whereas patients with severe COVID-19 exhibited significantly lower levels compared to both the control group (p = 0.002) and patients with moderate disease (p < 0.001) (Figure 2b). Here, ADIPOQ is linked to COVID-19.